Analyze Treatment Protocols for Covid-19

Floor Speech

Date: Feb. 7, 2022
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. GROTHMAN. Madam Speaker, I would like to address the COVID pandemic. A lot of people are kind of bored and tired of hearing about it, but with 2,000 lives lost a day, we shouldn't keep our eye off the ball.

It seems to be most of the focus or time spent is on masks, government shutdowns, and vaccines. But some doctors in my district feel that the treatment, once people get to the hospital, is to blame. I hope our special committee looks at the treatment people get in the hospital, analyzing remdesivir and its cost of well over $3,000 a day, to ivermectin and hydroxychloroquine, together with the shortage of monoclonal antibodies.

Doctors in my district feel tens of thousands, if not hundreds of thousands, of lives could be saved if people were given something else once they got in the hospital. And just because that may not be as sexy or interesting, I think it is something our special subcommittee ought to take up and see if they can save some lives. It might take some standing up to the pharmaceutical industry.

BREAK IN TRANSCRIPT


Source
arrow_upward